Good CARMA: Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages.

MLA

Snyder, Christopher M., and Saar I. Gill. “Good CARMA: Turning Bad Tumor‐resident Myeloid Cells Good with Chimeric Antigen Receptor Macrophages.” Immunological Reviews, vol. 320, no. 1, Nov. 2023, pp. 236–49. EBSCOhost, https://doi.org/10.1111/imr.13231.

APA

Snyder, C. M., & Gill, S. I. (2023). Good CARMA: Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages. Immunological Reviews, 320(1), 236–249. https://doi.org/10.1111/imr.13231

Chicago

Snyder, Christopher M., and Saar I. Gill. 2023. “Good CARMA: Turning Bad Tumor‐resident Myeloid Cells Good with Chimeric Antigen Receptor Macrophages.” Immunological Reviews 320 (1): 236–49. doi:10.1111/imr.13231.